Principal component analysis was used to reduce the 3 items of pain intensity, 6 items of level of pain interference on patients�� routines, and 7 items of barrier statements. The former two were Pyrazofurin measured over three days while the latter only at a point in time. The analysis was run independently for each the three factors. For the first two, the raw data matrix recoded so that the average of the three data point was taken during data reduction. However, the raw data matrix of the barrier statement was taken as it is since it was measured only once. Then, the appropriateness of the data was assessed using KMO��s and Bartllet��s test. The assessment of the Scree plot showed that only one component was enough for each category of measurement. Finally, the analysis for each was run again by setting the number of components to be one and the type of extraction Varimax. The generated scores were then used for subsequent analysis using ANOVA, correlations and linear regression. Findings from this study should be interpreted and understood within the context of barriers of pain management in Africa, and postoperative pain management in Ethiopia, where, at the time of data collection, there was one national SR1848 general guideline prepared by the Federal Ministry of Health. This guideline is expected to chaperon professionals to effectively manage postoperative pain. This guideline was prepared to be in tune with the World Health Organization ladder of pain management. In hospitals of most developing countries pain management is derived from the medical staff��s experience, and is not always consistent with recommendations from organizations such as the APS. Postoperative pain medications are still prescribed on an as-needed basis, requiring patients to request pain medication, and interventions are implemented when patients are in severe pain. In most acute care settings, pethidine and intramuscular injection are the commonest prescription orders, neither of which is recommended by pain management guidelines.Maximum doses of paracetamol and non-steroidal anti-inflammatory drugs are rarely used unlike in the developed world. The high cost of opioids in developing countries compounded this problem.